C44.729 Squamous cell carcinoma of skin of left lower limb, including hip

Name of the Condition

• Squamous cell carcinoma of skin of left lower limb, including hip.

Summary

This condition refers to a malignant growth of squamous cell carcinoma (SCC) on the skin of the left lower limb, including the hip. SCC arises from squamous cells in the epidermis and is the second most common type of skin cancer. It typically grows more aggressively than basal cell carcinoma and may invade deeper tissues if left untreated.

Causes

The primary cause is genetic mutations in squamous skin cells, often triggered by chronic ultraviolet (UV) radiation exposure from sunlight or tanning devices. Other factors, such as environmental exposures or genetic predispositions, may contribute, but UV damage is the most significant risk factor.

Risk Factors

• UV Exposure: Prolonged or intense sunlight exposure without protection.
• Skin Type: Fair skin with less melanin, which offers less natural UV defense.
• Age: Higher incidence with advancing age.
• Prior Skin Cancers: Personal or family history of skin malignancies.
• Immunosuppression: Weakened immune systems may increase susceptibility.
• Chronic Skin Inflammation: Conditions like burns or ulcers may elevate risk.

Symptoms

• Visible Growths: Firm, red nodules or flat lesions with a scaly surface.
• Texture Changes: Rough, crusted, or ulcerated areas that may bleed or ooze.
• Growth Patterns: Lesions that grow slowly but may become larger or more irregular over time.

Diagnosis

Diagnosis typically involves a physical examination of the affected area, followed by a skin biopsy to confirm the presence of cancerous cells. The biopsy may be examined under a microscope to determine the type and extent of the carcinoma. Additional imaging or tests may be used to assess for deeper tissue invasion or metastasis.

Treatment Options

Treatment depends on the size, location, and stage of the carcinoma. Common options include surgical excision, Mohs micrographic surgery (for precise removal), cryotherapy, topical medications, or radiation therapy. Early-stage SCCs are often curable with localized treatments.

Prognosis and Follow-Up

Prognosis is generally favorable when detected and treated early, as SCC has a lower metastasis rate than melanoma. Regular follow-up appointments are recommended to monitor for recurrence or new skin cancers, especially in high-risk individuals.

Complications

If left untreated, SCC may invade surrounding tissues, nerves, or blood vessels, leading to disfigurement or functional impairment. In rare cases, it can metastasize to lymph nodes or other organs, increasing severity.

Lifestyle & Prevention

• Sun Protection: Use broad-spectrum sunscreen, wear protective clothing, and avoid peak sun hours.
• Skin Checks: Perform regular self-examinations and consult a dermatologist for annual screenings.
• Avoid Tanning Beds: Minimize exposure to artificial UV sources.
• Healthy Skin Habits: Quit smoking and maintain overall skin health to reduce risk.

When to Seek Professional Help

Seek medical attention if you notice new or changing skin lesions, persistent sores that do not heal, or growths with irregular borders, colors, or textures. Early evaluation is critical for effective treatment.

Tips for Medical Coders

This code (C44.729) specifies squamous cell carcinoma of the skin on the left lower limb, including the hip. Ensure documentation clearly identifies the laterality (left) and anatomic site (lower limb, including hip) to support accurate coding. Verify that the diagnosis aligns with clinical findings and that no more specific codes apply.